Table 3 Occurrence status of ADRs of safety specification by grade.
Safety specification system organ class; preferred term | Safety analysis set (N = 76) | ||||||
---|---|---|---|---|---|---|---|
All grades | Grade ≥ 3 | Grade 1 | Grade 2 | Grade 3 | Grade 4 | Grade 5 | |
Total, n (%) | 42 (55.26) | 13 (17.11) | 22 (28.95) | 19 (25.00) | 13 (17.11) | 0 | 0 |
Eye disorders, n (%) | 1 (1.32) | 0 | 0 | 1 (1.32) | 0 | 0 | 0 |
Retinal detachment | 1 (1.32) | 0 | 0 | 1 (1.32) | 0 | 0 | 0 |
Pyrexia, n (%) | 35 (46.05) | 3 (3.95) | 16 (21.05) | 16 (21.05) | 3 (3.95) | 0 | 0 |
Pyrexia | 35 (46.05) | 3 (3.95) | 16 (21.05) | 16 (21.05) | 3 (3.95) | 0 | 0 |
Hepatic impairment, n (%) | 8 (10.53) | 6 (7.89) | 2 (2.63) | 1 (1.32) | 6 (7.89) | 0 | 0 |
AST increased | 4 (5.26) | 3 (3.95) | 0 | 1 (1.32) | 3 (3.95) | 0 | 0 |
ALT increased | 4 (5.26) | 2 (2.63) | 1 (1.32) | 1 (1.32) | 2 (2.63) | 0 | 0 |
Abnormal hepatic function | 3 (3.95) | 2 (2.63) | 1 (1.32) | 0 | 2 (2.63) | 0 | 0 |
Gamma-glutamyl transferase increased | 1 (1.32) | 1 (1.32) | 0 | 0 | 1 (1.32) | 0 | 0 |
Liver disorder | 1 (1.32) | 1 (1.32) | 0 | 0 | 1 (1.32) | 0 | 0 |
Cardiac disorder, n (%) | 8 (10.53) | 1 (1.32) | 4 (5.26) | 3 (3.95) | 1 (1.32) | 0 | 0 |
Hemoptysis | 1 (1.32) | 1 (1.32) | 0 | 0 | 1 (1.32) | 0 | 0 |
Atrioventricular block first degree | 1 (1.32) | 0 | 1 (1.32) | 0 | 0 | 0 | 0 |
Edema peripheral | 2 (2.63) | 0 | 2 (2.63) | 0 | 0 | 0 | 0 |
Localized edema | 1 (1.32) | 0 | 1 (1.32) | 0 | 0 | 0 | 0 |
Left ventricular dysfunction | 1 (1.32) | 0 | 0 | 1 (1.32) | 0 | 0 | 0 |
Ejection fraction decreased | 2 (2.63) | 0 | 1 (1.32) | 1 (1.32) | 0 | 0 | 0 |
Cardiac disorders | 1 (1.32) | 0 | 0 | 1 (1.32) | 0 | 0 | 0 |
Rhabdomyolysis, n (%) | 9 (11.84) | 6 (7.89) | 3 (3.95) | 1 (1.32) | 6 (7.89) | 0 | 0 |
Rhabdomyolysis | 5 (6.58) | 4 (5.26) | 0 | 1 (1.32) | 4 (5.26) | 0 | 0 |
Blood CPK increased | 5 (6.58) | 2 (2.63) | 3 (3.95) | 0 | 2 (2.63) | 0 | 0 |